Last reviewed · How we verify
Perennial allergic rhinitis
Approved treatments
- Mizollen · Sanofi
- Depo-Medrol · Pfizer
Depo-Medrol works by binding to the glucocorticoid receptor, which then regulates the expression of genes involved in inflammation and immune response.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Perennial allergic rhinitis patent landscape — cliff calendar, originator estates, attackable patents
- Perennial allergic rhinitis treatment landscape brief
- Perennial allergic rhinitis treatment updates RSS
Frequently asked questions about Perennial allergic rhinitis
What drugs treat Perennial allergic rhinitis?
Tracked treatments include Mizollen, Depo-Medrol.
What is the treatment for Perennial allergic rhinitis?
Standard treatment for Perennial allergic rhinitis includes Mizollen, Depo-Medrol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Perennial allergic rhinitis patent cliff · Perennial allergic rhinitis CI report
- Treatment: Mizollen · Sanofi
- Treatment: Depo-Medrol · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing